(Q43035657)

12 November 2017

title

Influence of three successive antiviral treatments on viral heterogeneity in nonresponder chronic hepatitis C patients (English)

1 reference

12 November 2017

1 reference

M A Thelu

1

1 reference

12 November 2017

K Brengel-Pesce

2

1 reference

12 November 2017

V Leroy

3

1 reference

12 November 2017

V Attuil

4

1 reference

12 November 2017

E Drouet

5

1 reference

12 November 2017

J M Seigneurin

6

1 reference

12 November 2017

J P Zarski

7

1 reference

12 November 2017

publication date

1 December 2001

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

65

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

698-705

1 reference

Genetic organization and diversity of the hepatitis C virus

12 November 2017

cites work

1 reference

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region

21 January 2018

1 reference

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

21 January 2018

1 reference

Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

Quasispecies in viral persistence and pathogenesis of hepatitis C virus

21 January 2018

1 reference

Enhanced detection by PCR of hepatitis C virus RNA.

21 January 2018

1 reference

Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

21 January 2018

1 reference

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy

21 January 2018

1 reference

The treatment of chronic viral hepatitis

21 January 2018

1 reference

Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy

21 January 2018

1 reference

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

21 January 2018

1 reference

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy

21 January 2018

1 reference

Hepatitis C virus resistance to antiviral therapy.

21 January 2018

1 reference

Treatment of hepatitis C with interferon and ribavirin

21 January 2018

1 reference

Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy

21 January 2018

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain

21 January 2018

1 reference

Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group

21 January 2018

1 reference

The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy

21 January 2018

1 reference

Evolution of the hypervariable region of hepatitis C virus

21 January 2018

1 reference

Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome.

21 January 2018

1 reference

Restriction of hepatitis C virus heterogeneity during prolonged interferon-alpha therapy in relation to changes in virus load

21 January 2018

1 reference

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

21 January 2018

1 reference

Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.2093

1 reference

12 November 2017

1 reference